THE Therapeutic Goods Administration has released its latest Medicines Safety Update, detailing recent changes to Product Information relating from its safety monitoring activities.
The most recent changes to the document detail special warnings and precautions for Pfizer's DPL Amikacin, Arrow Pharma's Valtrex and Zoloft from Viatris - for the full update see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Dec 22
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Dec 22
